Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus

Deteriorated arterial function and high incidence of cardiovascular events characterise diabetes mellitus. Metformin and recent antidiabetic drugs, SGLT2 inhibitors, reduce cardiovascular events. We explored t...

Source: Cardiovascular Diabetology - December 3, 2018 Category: Cardiology Authors: Mojca Lunder, Miodrag Jani ć, Miha Japelj, Andrej Juretič, Andrej Janež and Mišo Šabovič Tags: Original investigation Source Type: research